Brendan Healy

Brendan Healy has extensive experience in the pharmaceutical industry, specializing in quality control, analytical technologies, and project management. With a background in analytical chemistry and quality assurance, Brendan has worked for various companies such as BioMarin Pharmaceutical Inc., Eli Lilly and Company, Janssen Biologics, DePuy Orthopaedics, Pfizer, and Cork Institute of Technology. Brendan's expertise includes managing release and stability studies for IND submissions, developing and validating analytical methods, and working on pre-clinical and clinical projects. Brendan also has a PhD in Development of Analytical Methods and methods for the Isolation and purification of Natural Toxins.